|
Volumn 2, Issue 4, 2001, Pages 317-327
|
Pharmacogenetics - Legal, ethical and regulatory considerations
a a a |
Author keywords
Clinical trials; Legal; Pharmacogenetics; Regulatory
|
Indexed keywords
DRUG;
CODING;
CONFIDENTIALITY;
CONTROLLED STUDY;
DRUG CHOICE;
DRUG DEVELOPMENT;
DRUG EFFICACY;
DRUG EXPOSURE;
DRUG RESEARCH;
DRUG SAFETY;
EDITORIAL;
GENETIC VARIABILITY;
INFORMED CONSENT;
LEGAL ASPECT;
MEDICAL ETHICS;
PHARMACOGENETICS;
CLINICAL TRIAL;
GENETIC POLYMORPHISM;
GENETIC PRIVACY;
HUMAN;
PRACTICE GUIDELINE;
REVIEW;
CLINICAL TRIALS;
GENETIC PRIVACY;
GUIDELINES;
HUMAN;
INFORMED CONSENT;
PHARMACOGENETICS;
POLYMORPHISM (GENETICS);
|
EID: 0035198686
PISSN: 14622416
EISSN: None
Source Type: Journal
DOI: 10.1517/14622416.2.4.317 Document Type: Editorial |
Times cited : (35)
|
References (19)
|